We observed the increased expression of CXCR4 by PB CD34+ cells not only in MDS patients but also in AA patients who exhibited clonal hematopoiesis associated with somatic mutations of myeloid malignancy‐related genes. The gene discussed is CD34; the disease is myelodysplastic syndrome.